NCNA

About NuCana plc American Depositary Share (NCNA) Stock

NuCana plc American Depositary Share (NCNA) closed the 2026-09-17 session at $1.33, up 2.31% versus the previous close (+0.03). The stock opened at $1.33 and traded between $1.30 and $1.37 during that session. Session trading volume was 47K shares. The volume-weighted average price (VWAP) is $1.34.

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.

NuCana plc American Depositary Share has a market capitalization of $5.4 million. NCNA is listed on the XNAS exchange. The company employs approximately 12 people. The recorded listing date is 2017-09-28.

On this page you can find market NCNA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors.